SHPRH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.072620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.212000E-01
Normal-vs-Stage2
9.668000E-02
Normal-vs-Stage3
8.985900E-02
Normal-vs-Stage4
8.372600E-01
Stage1-vs-Stage2
2.350600E-01
Stage1-vs-Stage3
1.396390E-01
Stage1-vs-Stage4
7.800000E-01
Stage2-vs-Stage3
2.189000E-01
Stage2-vs-Stage4
1.458650E-01
Stage3-vs-Stage4
1.210410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.053160E-01
Normal-vs-AfricanAmerican
4.869600E-01
Normal-vs-Asian
1.003580E-01
Caucasian-vs-AfricanAmerican
3.840800E-01
Caucasian-vs-Asian
3.569800E-01
AfricanAmerican-vs-Asian
2.213400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.703600E-02
Normal-vs-Female
1.838380E-01
Male-vs-Female
4.376200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.923400E-01
Normal-vs-Age(41-60Yrs)
2.651600E-01
Normal-vs-Age(61-80Yrs)
6.877700E-02
Normal-vs-Age(81-100Yrs)
1.038780E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.499000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.980200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.214200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.305200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.203000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.191600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.303700E-02
Normal-vs-Daily Drinker
9.160700E-03
Normal-vs-Weekly Drinker
1.189360E-01
Normal-vs-Occasional Drinker
1.842980E-01
Normal-vs-Social Drinker
4.821600E-01
Non Drinker-vs-Daily Drinker
9.715600E-02
Non Drinker-vs-Weekly Drinker
9.433200E-01
Non Drinker-vs-Occasional Drinker
5.643200E-01
Non Drinker-vs-Social Drinker
3.158800E-01
Daily Drinker-vs-Weekly Drinker
2.186000E-01
Daily Drinker-vs-Occasional Drinker
6.196100E-02
Daily Drinker-vs-Social Drinker
6.488400E-02
Weekly Drinker-vs-Occasional Drinker
6.200000E-01
Weekly Drinker-vs-Social Drinker
3.509400E-01
Occasional Drinker-vs-Social Drinker
5.504800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.010380E-01
Normal-vs-Grade 2
8.788400E-02
Normal-vs-Grade 3
3.865800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.661600E-01
Grade 1-vs-Grade 3
3.892400E-01
Grade 1-vs-Grade 4
1.010380E-01
Grade 2-vs-Grade 3
2.457600E-01
Grade 2-vs-Grade 4
8.788400E-02
Grade 3-vs-Grade 4
3.865800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.292300E-02
Normal-vs-NonDiabetic
3.790300E-02
Diabetic-vs-NonDiabetic
6.050600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.854600E-01
Normal-vs-NoPancreatitis
5.440000E-02
Pancreatitis-vs-NoPancreatitis
6.252800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.141800E-01
Normal-vs-N1
8.542200E-02
N0-vs-N1
7.018000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.188800E-01
Normal-vs-TP53-NonMutant
4.271200E-01
TP53-Mutant-vs-TP53-NonMutant
7.163800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
